Clinical Trials Browser

Phase 1 × Hodgkin Disease × Biological Products × Clear all

NCT03383965 2017-12-27

CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

Phase 1 Unknown

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic